How it's studied to work

SS-31 (Elamipretide) is a synthetic peptide that targets mitochondria, the energy-producing structures within cells. It is mainly researched for its role in improving cellular energy production and reducing oxidative stress.

How it's studied to work

Research explores its binding to cardiolipin, a mitochondrial lipid, which is studied to help stabilize mitochondrial function — improving energy (ATP) production efficiency, reducing oxidative stress inside cells, and helping cells function better under stress such as fatigue, aging or metabolic strain.

Areas of research interest

Areas of research and experimental interest include cellular energy and fatigue, early-stage neuroprotective research, cellular protection against oxidative damage, and physical performance/recovery.

Who might consider researching it, and who should not

Discussed in the context of chronic fatigue or low energy, interest in mitochondrial-health or anti-aging research, and high physical or cognitive stress. It should be avoided by anyone pregnant or breastfeeding, anyone with a serious medical condition without supervision, anyone with active cancer, and anyone with unexplained neurological or systemic illness.

Reported effects to be aware of

Reported effects are limited in the available data — injection site irritation, headache, mild fatigue or energy shifts, and rare dizziness or nausea have been described. Long-term safety in healthy humans is not well established.